Ectopic expression of cdc2/cdc28 kinase subunit Homo sapiens 1 uncouples cyclin B metabolism from the mitotic spindle cell cycle checkpoint

Molecular and Cellular Biology

Volumn 18, Issue 11, 1998, Pages 6224-6237

  Hixon, Mary L ^a   Flores, Ana I ^a   Wagner, Mark W ^a   Gualberto, Antonio ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B; MUTANT PROTEIN; PROTEIN KINASE; PROTEIN P53;

ARTICLE; CELL CYCLE; DNA REPLICATION; FIBROBLAST; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

HOMO SAPIENS;

EID: 0031741136     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.11.6224     Document Type: Article

References (63)

1. Agapova, L. S., G. V. Ilyinskaya, N. A. Turovets, A. V. Ivanov, P. M. Chumakov, and B. P. Kopnin. 1996. Chromosome changes caused by alterations of p53 expression. Mutat. Res. 354:129-138.
2. Andreassen, P. R., and R. L. Margolis. 1994. Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J. Cell Biol. 127: 789-802.
3. Basi, G., and G. Draetta. 1995. The cdc2 kinase: structure, activation, and its role at mitosis in vertebrate cells, p. 106-134. In C. Hutchison and D. M. Glover (ed.), Cell cycle control, vol. 10. Oxford University Press, Oxford, United Kingdom.
4. Basi, G., and G. Draetta. 1995. p13suc1 of Schizosaccharomyces pombe regulates two distinct forms of the mitotic cdc2 kinase. Mol. Cell. Biol. 15: 2028-2036.
5. Bischoff, F. Z., S. O. Yim, S. Pathak, G. Grant, M. J. Siciliano, B. C. Giovanella, L. C. Strong, and M. A. Tainsky. 1990. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res. 50:7979-7984.
6. Bischoff, J. R., P. N. Friedman, D. R. Marshak, C. Prives, and D. Beach. 1990. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl. Acad. Sci. USA 87:4766-4770.
7. Bourne, Y., M. H. Watson, M. J. Hickey, W. Holmes, W. Rocque, S. I. Reed, and J. A. Tainer. 1996. Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1. Cell 84:863-874.
8. Brizuela, L., G. Draetta, and D. Beach. 1987. p13suc1 acts in the fission yeast cell division cycle as a component of the p34cdc2 protein kinase. EMBO J. 6:3507-3514.
9. Chen, P. L., Y. M. Chen, R. Bookstein, and W. H. Lee. 1990. Genetic mechanisms of tumor suppression by the human p53 gene. Science 250: 1576-1580.
10. Chen, Y., P. L. Chen, and W. H. Lee. 1994. Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle. Mol. Cell. Biol. 14:6764-6772.
11. Chin, K. V., K. Ueda, I. Pastan, and M. M. Gottesman. 1992. Modulation ot activity of the promoter of the human MDR1 gene by Ras and p53. Science 255:459-462.
12. Coleman, W. B., J. W. Grisham, and G. J. Smith. 1994. Morphologic transformation of the C3H 10T1/2 cell line is accompanied by altered expression of the p53 tumor suppressor gene. Carcinogenesis 15:145-152.
13. Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and B. J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
14. Deb, S., C. T. Jackson, M. A. Subler, and D. W. Martin. 1992. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells. J. Virol. 66:6164-6170.
15. De Veylder, L., G. Segers, N. Glab, P. Casteels, M. Van Montagu, and D. Inze. 1997. The Arabidopsis Cks1At protein binds the cyclin-dependent kinases cdc2aAt and cdc2bAt. FEBS Lett. 412:446-452.
16. Di Leonardo, A., S. H. Khan, S. P. Linke, V. Greco, G. Seidita, and G. M. Wahl. 1997. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57:1013-1019.
17. Dittmer, D., S. Pati, G. Zambetti, S. Chu, A. K. Teresky, M. Moore, C. Finlay, and A. J. Levine. 1993. Gain of function mutations in p53. Nat. Genet. 4:42-46.
18. Draetta, G., L. Brizuela, J. Potashkin, and D. Beach. 1987. Identification of p34 and p13, human homologs of the cell cycle regulators of fission yeast encoded by cdc2+ and suc1+. Cell 50:319-325.
19. Elledge, S. J. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672.
20. Endicott, J. A., and P. Nurse. 1995. The cell cycle and suc1: from structure to function? Structure 3:321-325.
21. Finlay, C. A., P. W. Hinds, T. H. Tan, D. Eliyahu, M. Oren, and A. J. Levine. 1988. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol. 8:531-539.
22. Gualberto, A., K. Aldape, K. Kozakiewicz, and T. D. Tlsty. 1998. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc. Natl. Acad. Sci. USA 95:5166-5171.
23. Gualberto, A., and A. S. Baldwin, Jr. 1995. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat. J. Biol. Chem. 270:19680-19683.
24. Gualberto, A., M. L. Hixon, T. S. Finco, N. D. Perkins, G. J. Nabel, and A. S. Baldwin, Jr. 1995. A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat. Mol. Cell. Biol. 15:3450-3459.
25. Gualberto, A., G. Marquez, M. Carballo, G. L. Youngblood, S. W. R. Hunt, A. S. Baldwin, and F. Sobrino. 1998. p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties. J. Biol. Chem. 273:7088-7093.
26. Haibert, C. L., G. W. Demers, and D. A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66:2125-2134.
27. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
28. Hayles, J., D. Beach, B. Durkacz, and P. Nurse. 1986. The fission yeast cell cycle control gene cdc2: isolation of a sequence suc1 that suppresses cdc2 mutant function. Mol. Gen. Genet. 202:291-293.
29. Hermeking, H., C. Lengauer, K. Polyak, T.-C. He, L. Zhang, S. Thiagalingam, K. W. Kinzler, and B. Vogelstein. 1998. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1:3-11.
30. Hindley, J., G. Phear, M. Stein, and D. Beach. 1987. Sucl+ encodes a predicted 13-kilodalton protein that is essential for cell viability and is directly involved in the division cycle of Schizosaccharomyces pombe. Mol. Cell. Biol. 7:504-511.
31. Hsiao, M., J. Low, E. Dorn, D. Ku, P. Pattengale, J. Yeargin, and M. Haas. 1994. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Am. J. Pathol. 145:702-714.
32. Iwamoto, K. S., T. Mizuno, T. Ito, N. Tsuyama, S. Kyoizumi, and T.Seyama. 1996. Gain-of-function p53 mutations enhance alteration of the T-cell receptor following X-irradiation, independently of the cell cycle and cell survival. Cancer Res. 56:3862-3865.
33. Kern, S. E., J. A. Pietenpol, S. Thiagalingam, A. Seymour, K. W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830.
34. Kung, A. L., S. W. Sherwood, and R. T. Schimke. 1990. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl. Acad. Sci. USA 87:9553-9557.
35. Lanni, J. S., and T. Jacks. 1998. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18: 1055-1064.
36. Levine, A. J., M. C. Wu, A. Chang, A. Silver, E. F. Attiyeh, J. Lin, and C. B. Epstein. 1995. The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype. Ann. N. Y. Acad. Sci. 768:111-128.
37. Lin, J., A. K. Teresky, and A. J. Levine. 1995. Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene 10:2387-2390.
38. Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
39. Malkin, D., F. P. Li, L. C. Strong, J. F. Fraumeni, Jr., C. E. Nelson, D. H. Kim, J. Kassel, M. A. Gryka, F. Z. Bischoff, M. A. Tainsky, et al. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238.
40. Milner, J. and J. V. Watson. 1990. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein. Oncogene 5:1683-1690.
41. Minn, A. J., L. H. Boise, and C. B. Thompson. 1996. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10:2621-2631.
42. Moreno, S., J. Hayles, and P. Nurse. 1989. Regulation of p34cdc2 protein kinase during mitosis. Cell 58:361-372.
43. 42a. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
44. Mottram. J. C., and K. M. Grant. 1996. Leishmania mexicana p12cks1, a homologue of fission yeast p13suc1, associates with a stage-regulated histone H1 kinase. Biochem. J. 316:833-839.
45. Muller, B. F., D. Paulsen, and W. Deppert. 1996. Specific binding of MAR/ SAR DNA-elements by mutant p53. Oncogene 12:1941-1952.
46. Murphy, M., A. Hinman, and A. J. Levine. 1996. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10: 2971-2980.
47. 2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18:629-643.
48. Norbury, C., and P. Nurse. 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441-470.
49. Ookata, K., S. Hisanaga, E. Okumura, and T. Kishimoto. 1993. Association of p34cdc2/cyclin B complex with microtubules in starfish oocytes. J. Cell Sci. 105:873-881.
50. Patra, D., and W. G. Dunphy. 1996. Xe-p9, a Xenopus Suc1/Cks homolog, has multiple essential roles in cell cycle control. Genes Dev. 10:1503-1515.
51. Peled, A., D. Schwartz, N. B. Elkind, R. Wolkowicz, R. Li, and V. Rotter. 1996. The role of p53 in the induction of polyploidity of myelomonocytic leukemic M1/2 cells. Oncogene 13:1677-1685.
52. Pines, J., and T. Hunter. 1989. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58:833-846.
53. Reed, S. I., J. Ferguson, and J. C. Groppe. 1982. Preliminary characterization of the transcriptional and translational products of the Saccharomyces cerevisiae cell division cycle gene CDC28. Mol. Cell. Biol. 2:412-425.
54. Richardson, H. E., C. S. Stueland, J. Thomas, P. Russell, and S. I. Reed. 1990. Human cDNAs encoding homologs of the small p34cdc28/cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe. Genes Dev. 4:1332-1344.
55. Rudner, A. D., and A. W. Murray. 1996. The spindle assembly checkpoint. Curr. Opin. Cell Biol. 8:773-780.
56. Simon, K. E., H. H. Cha, and G. L. Firestone. 1995. Transforming growth factor beta down-regulation of CKShs1 transcripts in growth-inhibited epithelial cells. Cell Growth Differ. 6:1261-1269.
57. Soddu, S., G. Blandino, R. Scardigli, S. Coen, A. Marchetti, M. G. Rizzo, G. Bossi, L. Cimino, M. Crescenzi, and A. Sacchi. 1996. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol. 134: 193-204.
58. Srivastava, S., Z. Q. Zou, K. Pirollo, W. Blattner, and E. H. Chang. 1990. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747-749.
59. Subler, M. A., D. W. Martin, and S. Deb. 1994. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53. J. Virol. 68:103-110.
60. Sun, Y., K. Nakamura, E. Wendel, and N. Colburn. 1993. Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. USA 90:2827-2831.
61. Tang, Y., and S. I. Reed. 1993. The Cdk-associated protein Cks1 functions both in G1 and G2 in Saccharomyces cerevisiae. Genes Dev. 7:822-832.
62. Ullrich, S. J., C. W. Anderson, W. E. Mercer, and E. Appella. 1992. The p53 tumor suppressor protein, a modulator of cell proliferation. J. Biol. Chem. 267:15259-15262.
63. Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.